InnoSkel

As venture capital financings for biopharmaceutical companies continues to head into record-breaking territory again in 2021, Illumina Ventures and Jeito Capital announced two new venture capital fund

After a couple of decades of research, Alentis Therapeutics is close to advancing its anti-fibrotic molecules into the clinic, armed with $67m of new funding. Alentis, a Switzerland-based biotech, i

Biopharmaceutical companies developing therapies for neurological diseases are in the midst of a boom, not only in terms of novel approaches to treating intractable diseases but also in terms of attra